About Annora Pharma Private Limited
Data last updated:
Annora Pharma Private Limited is a private limited company based in Telangana, India, a subsidiary of Hetero Labs Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2015PTC101939. Its GSTIN is 36AANCA9470A2ZL (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹316 Cr and a paid-up capital of ₹271 Cr. It is led by directors including Mahesh Ramappa Kamalamma Hassan and Palleswara Rao Palapatla Govada.
Its last annual general meeting (AGM) was held on 05 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sy.No.261 Plot No.5 7 8 9 13 And 14, Telangana, India – 502313.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,493.96 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹225.59 Cr (net margin 15.1%) and EBITDA of ₹398.76 Cr (EBITDA margin 26.7%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 68% over five years.
The company is associated with 1 brand: ANNORA Pharma. As per MCA filings, the company has open charges of ₹610.82 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it. The company has 4 deals on record (2 funding rounds, 1 secondary share transfer, 1 acquisition), with disclosed funding of ₹150 Cr; the latest was in March 2024. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is MSN Pharmachem Private Limited with revenue of ₹1,716.51 Cr. The company has 10 MSME Form 1 returns on record between 2019 and 2024, listing 206 overdue payments to 35 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website annorapharma.com.
Company details
Contact details
Annora Pharma Private Limited's registered office is in Telangana. Its website is annorapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSy.No.261 Plot No.5 7 8 9 13 And 14, Telangana, India – 502313
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Annora Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Annora Pharma operates one associated brand: ANNORA Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing of formulations like tablets and capsules, adhering to global standards in India. | annorapharma.com |
Business activity
The main business activity of Annora Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Annora Pharma Private Limited, buy the company report.
Financials of Annora Pharma Private Limited
FY 2025 filings availableAnnora Pharma Private Limited reported revenue of ₹1,493.96 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 68% over five years, including 22% growth in the latest year. EBITDA rose 77% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹398.76 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹225.59 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.7% | ||||
| Net Profit Margin | 15.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Annora Pharma Private Limited, buy the company report.
Board of directors and KMP of Annora Pharma Private Limited
Annora Pharma Private Limited currently reports 4 directors and 1 key managerial person. 4 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Ramappa Kamalamma Hassan Also directs: Aspiro Pharma Limited | Director | 30 Mar 2018 | 8 Years 6 Months | Current |
| Palleswara Rao Palapatla Govada Also directs: Wallet Pharma Private Limited | Director | 26 Nov 2015 | 10 Years 11 Months | Current |
| Bhaskarreddy Pabbatireddy | Director | 05 Mar 2020 | 6 Years 7 Months | Current |
| Govindaraju Bhavani Also directs: Hetero Biopharma Limited, Hetero Labs Limited | Director | 30 Jun 2022 | 4 Years 3 Months | Current |
| Kiran Kumar Manikwar Also directs: Manjeet & Kiran Associates LLP | Company Secretary | 21 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Annora Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MSN Pharmachem Private Limited | ₹1,716.51 Cr (FY 2024) | 40.0% | Hyderabad, Telangana, India | |||
| Bharat Biotech International Limited | ₹1,699.59 Cr (FY 2025) | 4.0% | Hyderabad, Telangana, India | |||
| Indoco Remedies Limited | ₹1,670.37 Cr (FY 2025) | -9.0% | Mumbai, Maharashtra, India | |||
| Annora Pharma Private Limitedthis company | ₹1,493.96 Cr (FY 2025) | ₹225.59 Cr | 15.1% | 22.0% | Telangana, India | |
| Synthimed Labs Private Limited | ₹1,478.44 Cr (FY 2025) | 25706.0% | Chandigarh, India | |||
| Onesource Specialty Pharma Limited | ₹1,462.33 Cr (FY 2025) | 730.0% | Thane, Maharashtra, India | |||
| Par Formulations Private Limited | ₹1,462.09 Cr (FY 2025) | 5.0% | Chennai, Tamil Nadu, India | |||
| Encube Ethicals Private Limited | ₹1,369 Cr (FY 2025) | 25.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Annora Pharma Private Limited, buy the company report.
Auditor
Annora Pharma Private Limited is audited by M V Narayana Reddy & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M V Narayana Reddy & Co | FY 2023 | 002370S |
Shareholding
The shareholding of Annora Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Annora Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Dec 2024 | 101022522 | Others | ₹214.5 Cr | Open | |
| 20 Dec 2023 | 100844888 | Axis Bank Limited | ₹160 Cr | Open | |
| 22 Mar 2023 | 100708832 | Others | ₹9 Lakh | Open | |
| 10 Sep 2022 | 100658192 | Others | ₹9 Lakh | Open | |
| 30 Apr 2022 | 100602176 | Others | ₹38 Lakh | Open |
To see the full charge records of Annora Pharma Private Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Annora Pharma Private Limited has 4 deals on record (2 funding rounds, 1 secondary share transfer, 1 acquisition), with disclosed funding of ₹150 Cr; the latest was in March 2024.
Deals on record (3 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Seller: Hetero Labs Limited |
| Mar 2022 | Funding round | ₹135 Cr | Investors: Hetero Labs Limited |
| Mar 2019 | Acquisition | ₹150 Cr | Buyer: Hetero Labs Limited |
To see the full deal history of Annora Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Annora Pharma Private Limited has 2 court cases on record: 1 filed by Annora Pharma, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kota, Rajasthan | Court case (Cr.Reg.Case) | Filed against the company by State | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against The State of Telangana and 13 others | Disposed |
To see the full case history of Annora Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Annora Pharma Private Limited has 10 MSME Form 1 returns on record between 2019 and 2024, listing 206 overdue payments to 35 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 35)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| RK Timber Traders | |||
| S.S.P. Packaging Industries Private Limited | |||
| Bowman & Archer Pharma Machines (India) Private Limited | |||
| Nicomac Taikisha Clean Rooms Private Limited | |||
| Ardelisys Technologies Private Limited |
To see the full MSME payment records of Annora Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Annora Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AANCA9470A2ZL | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Annora Pharma Private Limited, buy the company report.
Recent activity
Annora Pharma Private Limited has 9 board changes on record since 2015: 7 appointments and 2 cessations. The latest: Chandra Sekhar Tumuluru ceased to be Director on 05 Sep 2025.
16 earlier events are in the company report.
Frequently asked questions
Annora Pharma is an active private limited company based in Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 November 2015 (11+ years old) and is registered under CIN U24100TG2015PTC101939.
Annora Pharma has 5 current directors and KMP:
- Mahesh Ramappa Kamalamma Hassan - Director
- Palleswara Rao Palapatla Govada - Director
- Bhaskarreddy Pabbatireddy - Director
- Govindaraju Bhavani - Director
- Kiran Kumar Manikwar - Company Secretary
The latest financial statements of Annora Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 05 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Annora Pharma is 36AANCA9470A2ZL, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Annora Pharma is U24100TG2015PTC101939. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Annora Pharma has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the district courts.
Annora Pharma was incorporated on 26 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Annora Pharma has 4 deals on record (2 funding rounds, 1 secondary share transfer, 1 acquisition), with disclosed funding of ₹150 Cr; the latest was in March 2024.
The peers of Annora Pharma by revenue are MSN Pharmachem Private Limited, Bharat Biotech International Limited, Indoco Remedies Limited, Synthimed Labs Private Limited, Onesource Specialty Pharma Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chandra Sekhar Tumuluru ceased to be Director on 05 Sep 2025. Kiran Kumar Manikwar was appointed as Company Secretary on 21 Mar 2025. Govindaraju Bhavani was appointed as Director on 30 Jun 2022. Annora Pharma has 9 board changes on record in total.
Annora Pharma has 10 MSME Form 1 returns on record between 2019 and 2024, listing 206 overdue payments to 35 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Annora Pharma can be reached through the website annorapharma.com. Its registered office is in Telangana, India.